103 related articles for article (PubMed ID: 19997710)
1. HLA typing in an IFN-alpha-induced scar sarcoidosis: possible pathogenetic and clinical implications.
Zampino MR; Corazza M; Borghi A; Marzola A; Virgili A
Acta Derm Venereol; 2009 Nov; 89(6):661-2. PubMed ID: 19997710
[No Abstract] [Full Text] [Related]
2. [Cutaneous sarcoidosis after treatment with interferon for hepatitis C: A not entirely rare but often overlooked reaction].
Waltschew A
Pathologe; 2016 Mar; 37(2):184-6. PubMed ID: 26769217
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
4. [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].
Bruch-Gerharz D; Reifenberger J
Hautarzt; 2006 Apr; 57(4):317-35. PubMed ID: 16523277
[No Abstract] [Full Text] [Related]
5. Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature.
López V; Molina I; Monteagudo C; Jordá E
Int J Dermatol; 2011 Mar; 50(3):287-91. PubMed ID: 21342161
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
Honsová E; Sticová E; Sperl J
Cesk Patol; 2007 Jan; 43(1):27-30. PubMed ID: 17370474
[TBL] [Abstract][Full Text] [Related]
7. [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
Savoye G; Goria O; Herve S; Riachi G; Noblesse I; Bastien L; Courville P; Lerebours E
Gastroenterol Clin Biol; 2000; 24(6-7):679. PubMed ID: 10962394
[No Abstract] [Full Text] [Related]
8. Interferon induced sarcoidosis with cutaneous involvement along lines of venous drainage in a former intravenous drug user.
Shuja F; Kavoussi SC; Mir MR; Jogi RP; Rosen T
Dermatol Online J; 2009 Dec; 15(12):4. PubMed ID: 20040254
[No Abstract] [Full Text] [Related]
9. Bullous lesions at polyethylene glycol interferon-alpha-2a inoculation site in a hepatitis C virus-infected subject.
Montesu MA; Siddi V; Satta R; Pirodda C; Cottoni F
Acta Derm Venereol; 2007; 87(5):433-4. PubMed ID: 17721655
[No Abstract] [Full Text] [Related]
10. Sarcoidosis or foreign-body granulomatous reaction during interferon treatment?
Bitetto D; Fumolo E; Fabris C; Toniutto P
Liver Int; 2010 Aug; 30(7):1083-4; author reply 1084. PubMed ID: 20214737
[No Abstract] [Full Text] [Related]
11. [Cutaneopulmonary sarcoidosis during pegylated interferon plus ribavirin therapy].
Sánchez-Ruano JJ; Artaza-Varasa T; Gómez-Rodríguez R; González de Frutos C; Repiso-Ortega A; Alcántara-Torres M
Gastroenterol Hepatol; 2006 Mar; 29(3):150. PubMed ID: 16507282
[No Abstract] [Full Text] [Related]
12. Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b.
Neglia V; Sookoian S; Herrera M; Abeldaño A; Kien MC; Chouela E; Frider B
J Cutan Med Surg; 2001; 5(5):406-8. PubMed ID: 11915769
[TBL] [Abstract][Full Text] [Related]
13. Sarcoidosis caused by interferon therapy.
Celik G; Sen E; Ulger AF; Kumbasar OO; Bozkaya H; Alper D; Karayalcin S
Respirology; 2005 Sep; 10(4):535-40. PubMed ID: 16135181
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous necrosis complicating the injection of pegylated interferon alpha-2b in a patient with chronic hepatitis C.
Rosina P; Girolomoni G
Acta Dermatovenerol Croat; 2008; 16(1):35-7. PubMed ID: 18358108
[TBL] [Abstract][Full Text] [Related]
15. Development of sarcoidosis following completion of treatment for hepatitis C with pegylated interferon-{alpha}2a and ribavirin: a case report and literature review.
Gayet AR; Plaisance P; Bergmann JF; Mouly S
Clin Med Res; 2010 Dec; 8(3-4):163-7. PubMed ID: 20852086
[TBL] [Abstract][Full Text] [Related]
16. A Post-cure Complication.
Nunes J; Marinho RT; Velosa J
Am J Med; 2010 Mar; 123(3):223-4. PubMed ID: 20193828
[No Abstract] [Full Text] [Related]
17. Pegylated interferon alfa-induced sarcoidosis: two sides of the same coin.
Guilabert A; Bosch X; Julià M; Iranzo P; Mascaró JM
Br J Dermatol; 2005 Feb; 152(2):377-9. PubMed ID: 15727663
[No Abstract] [Full Text] [Related]
18. Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C.
Chiang CH; Lai FJ
J Formos Med Assoc; 2014 Dec; 113(12):981-2. PubMed ID: 25187070
[No Abstract] [Full Text] [Related]
19. [Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395712
[No Abstract] [Full Text] [Related]
20. [Sarcoidosis associated with the treatment of hepatitis C: case report and Spanish literature review].
Trullàs JC; Hernández-Marcet P; Bisbe J
Med Clin (Barc); 2011 May; 136(14):649-50. PubMed ID: 21051060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
